Finance Home - My Yahoo - Yahoo! - Help

Thursday, November 26, 2009, 9:47PM ET - U.S. Markets Closed for Thanksgiving Day. Dow  0.29% Nasdaq  0.32%

Optimer Pharmaceuticals, Inc. (OPTR)

On Nov 25: 11.46   0.14 (1.21%)

MORE ON OPTR

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Nov 24, 2009 • Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference PR Newswire (Tue, Nov 24) Thu, Nov 12, 2009 • Optimer Pharma upgraded by Oppenheimer Briefing.com (Thu, Nov 12) • Optimer Pharmaceuticals Completes Enrollment in Second Fidaxomicin Phase 3 Clinical Trial in Patients With Clostridium difficile Infection PR Newswire (Thu, Nov 12) Wed, Nov 11, 2009 • Optimer Beats Estimates Zacks.com (Wed, Nov 11) Sat, Nov 7, 2009 • OPTIMER PHARMACEUTICALS INC Financials EDGAR Online Financials (Sat, Nov 7) Wed, Nov 4, 2009 • New Star Analyst Rankings for Optimer Pharmaceuticals, Inc. StarMine (Wed, Nov 4) Tue, Nov 3, 2009 • OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online (Tue, Nov 3) • Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results PR Newswire (Tue, Nov 3) Sat, Oct 31, 2009 • Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting PR Newswire (Sat, Oct 31) Mon, Oct 26, 2009 • Optimer Pharmaceuticals to Present at November 2009 Investor Conferences PR Newswire (Mon, Oct 26) Fri, Oct 23, 2009 • Biotech Calendar: Key Upcoming Trials at TheStreet.com (Fri, Oct 23) Tue, Oct 20, 2009 • Galleon's Biotech Stock Holdings: BioBuzz at TheStreet.com (Tue, Oct 20) • Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations Wall Street Transcript (Tue, Oct 20) Mon, Oct 19, 2009 • Optimer Pharmaceuticals Announces Presentations of Additional Data From the Fidaxomicin North American Phase 3 Trial at Upcoming IDSA Annual Meeting PR Newswire (Mon, Oct 19) Mon, Sep 28, 2009 • Optimer Pharmaceuticals to Present at October 2009 Investor Conferences PR Newswire (Mon, Sep 28) Tue, Sep 15, 2009 • Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) PR Newswire (Tue, Sep 15) Mon, Sep 14, 2009 • Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) PR Newswire (Mon, Sep 14) Thu, Sep 3, 2009 • Optimer Pharmaceuticals to Present at September 2009 Investor Conferences PR Newswire (Thu, Sep 3) Wed, Sep 2, 2009 • Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting PR Newswire (Wed, Sep 2) Fri, Aug 7, 2009 • OPTIMER PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Aug 7) Older Headlines - Download Recent Headlines View headlines from: Fri, Aug 7, 2009Fri, Jul 31, 2009Fri, Jul 24, 2009Fri, Jul 17, 2009Fri, Jul 10, 2009Fri, Jul 3, 2009Fri, Jun 26, 2009Fri, Jun 19, 2009Fri, Jun 12, 2009Fri, Jun 5, 2009 Add OPTR News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage